ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Congressional Action Imminent On Cancer Ac Renewal, Hew Money Bills; Veto Threatened

September 8, 1978

ACS Supports NCI’s Bypass Budget In Resolution

March 20, 1992

Agreement Reached On Most CCOP Issues; First RFA To Be Out March, Awards To Be Made In Fiscal 1983

January 22, 1982

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients

November 27, 2009

In Brief: NCI Construction Authority To Continue Under Pane’s Plan: NCAB hearing In Philadelphia

March 11, 1988